Global Genotyping Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities (2025)

05-02-2025 11:45 AM CET |

Press release from: The Business Research Company

Genotyping

The Genotyping Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Genotyping Market Size Expected to Be by 2034?
Recently, the genotyping market has experienced a swift expansion. The market is projected to surge from $23.04 billion in 2024 to $26.63 billion in 2025, reflecting a Compound Annual Growth Rate (CAGR) of 15.6%. This remarkable growth during the historical period can be linked to government-led initiatives and funding, a steep drop in genotyping costs, the broadening of biobanks and genetic databases, a rising incidence of genetic disorders, and advancements in pharmacogenomics and drug development.

See Also

china > makeup > CAre Global suppliers

In the coming years, the genotyping market is predicted to experience significant expansion. The market is projected to reach $51.43 billion in 2029, with a compound annual growth rate (CAGR) of 17.9%. This anticipated growth during the forecast period is largely due to the increasing usage in clinical diagnostics, escalating demand for personalized medication, an upsurge in research and development endeavors, and broadening applications in agriculture and livestock. Key trends expected throughout this forecast period comprise growing demand for pharmacogenomics, advancements in next-generation sequencing (ngs), the burgeoning initiatives in precision medicine, the expansion of direct-to-consumer (dtc) genetic testing, and a heightened focus on cancer genomics and personalized treatments.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12059

What Are the Emerging Segments Within the Genotyping Market?
The genotyping market covered in this report is segmented -

1) By Product And Services: Instruments, Reagents And Kits, Bioinformatics, Genotyping Service
2) By Technology: Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction, Matrix-Assisted Laser Desorption Or Ionization (Maldi-Tof) Mass Spectrometry, Other Technologies
3) By Application: Pharmacogenomics, Diagnostics And Personalized Medicine, Animal Genetics, Agricultural Biotechnology, Other Applications
4) By End-User: Pharmaceutical And Biopharmaceutical Companies, Diagnostics And Research Laboratories, Academic Institutes, Other End-Users

Subsegments:
1) By Instruments: Sequencers, PCR Machines, Microarrays, Genotyping Platforms
2) By Reagents And Kits: DNA Extraction Kits, PCR Reagents, SNP Genotyping Kits, Next-Generation Sequencing (NGS) Kits
3) By Bioinformatics: Data Analysis Software, Genomic Data Management Tools, Cloud-based Solutions
4) By Genotyping Services: Contract Research Organizations (CRO) Services, Custom Genotyping Services, Sample Preparation Services

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12059&type=smp

What Long-Term Drivers Are Shaping Genotyping Market Trends?
The genotyping market's growth is anticipated to be fueled by the escalating rates of cancer and genetic disorders. The term cancer encompasses a vast array of diseases that can emerge in virtually any body organ or tissue, while a genetic disorder manifests due to some abnormalities in the normal DNA sequence. By employing genotyping, researchers can scrutinize genetic variations like single nucleotide differences, copy number alterations, and significant structural transformations in the DNA. Genotyping, or genetic testing, aims to identify specific gene changes that might elevate an individual's chance of contracting certain cancers. The World Health Organization, a specialized Switzerland-based agency concentrating on global public health, for example, disclosed in February 2024 that about 20 million fresh cases of cancer were documented in 2022, triggering 9.7 million deaths. Concurrently, it's estimated that about 53.5 million people were alive five years post their cancer diagnosis. In another example, Gene People UK, a UK-based registered charitable organization, revealed in February 2023 that 1 out of every 25 children suffers from a genetic disorder. This translates to 30,000 newly diagnosed infants and children each year in the UK alone, and over 2.4 million children and adults living with a genetic disorder. Consequently, the rising incidence of cancer and genetic disorders is stimulating the expansion of the genotyping market.

Who Are the Top Competitors in Key Genotyping Market Segments?
Major companies operating in the genotyping market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Eurofins Scientific SE, Agilent Technologies, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv, Takara Bio Inc., Integrated DNA Technologies Ltd., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies, Macrogen Inc., Pacific Biosciences of California, Standard BioTools Inc., GENEWIZ, Transnetyx, Agena Bioscience Inc., Genotypic Technology Pvt Ltd., BMG LABTECH GmbH, Bioline, Biofortuna Limited, Xcelris Genomics

What Genotyping Market Trends Are Gaining Traction Across Different Segments?
The emergence of product innovations is a significant trend catching attention in the genotyping market. To maintain their market foothold, companies within the genotyping industry are turning towards unique solutions. For instance, in May 2022, Neogen, an American food safety firm, alongside Gencove Inc., an American sequencing platform provider for genome discovery, unveiled InfiniSEEK. This pioneering and affordable solution for whole genome sequencing and targeted SNP (single nucleotide polymorphism) analysis is the first-of-its-kind for cattle breeders. With InfiniSEEK, there now exists a reliable platform for managing over 400 bovine genetic traits and conditions, uncovering new factors affecting desired phenotypes, and reducing selection bias through comprehensive population sequencing. The launch of this exclusive service offers customers a comprehensive, affordable way to profile cattle globally, merging genome-wide sequencing data, specific genetic traits, and parentage indicators.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report

Which Regions Are Becoming Hubs for Genotyping Market Innovation?
North America was the largest region in genotyping market in 2024. The regions covered in the genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Genotyping Market?
2. What is the CAGR expected in the Genotyping Market?
3. What Are the Key Innovations Transforming the Genotyping Industry?
4. Which Region Is Leading the Genotyping Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.